Spin-Off

Event · Corporate Finance

Displaying items 141-147 of 147 in total

Serve Robotics' D.C. Gambit: Autonomous Delivery Hits Alexandria's Streets

Serve Robotics and Uber Eats launch sidewalk robots in Alexandria, Va., testing the scalability, economics, and public acceptance of last-mile automation.

Read full article

Serve Robotics' D.C. Gambit: Autonomous Delivery Hits Alexandria's Streets

Gary Clark: Unfiltered 7 months ago

BBOT's 'Breaker' Drug Aims to Sidestep a Major Oncology Hurdle

BridgeBio Oncology's new drug candidate BBO-10203 could redefine cancer therapy by avoiding a key toxicity, unlocking a vast market.

Read full article

BBOT's 'Breaker' Drug Aims to Sidestep a Major Oncology Hurdle

Gary Clark: Unfiltered 7 months ago

Capitalizing on the 'Viagra Gap': Daré's Bold Bet on Female Arousal

Daré Bioscience is targeting a 20M-woman market with a novel arousal cream. This is the story of its clever regulatory strategy and high-stakes bet.

Read full article

Capitalizing on the 'Viagra Gap': Daré's Bold Bet on Female Arousal

The Powell Perspective 7 months ago

Ledger's Korra Aims to Be the OS for a New Era of Risk Capital

Ledger Investing launches Korra, a battle-tested SaaS platform using AI to bring transparency and efficiency to the complex casualty ILS market.

Read full article

Ledger's Korra Aims to Be the OS for a New Era of Risk Capital

The Nelson Report 7 months ago

Prospect's New Fund Dangles 9% Yield: An Income Play or a High-Wire Act?

Prospect Enhanced Yield Fund's debut 9% distribution tempts income seekers, but a look into the structured credit market reveals a complex risk-reward.

Read full article

Prospect's New Fund Dangles 9% Yield: An Income Play or a High-Wire Act?

Innovation Spotlight: The Future of Business 8 months ago

The End of the Match Game: A New Era in Lifesaving Transplants

A medical breakthrough dismantles a core barrier in cancer treatment, making stem cell transplants a reality for nearly everyone, regardless of ancestry.

Read full article